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Background to the EPIC trial 
At least two-thirds of people living in care homes 
have dementia1 and many develop behaviours, 
such as agitation2. This can be upsetting for 
them, for other residents and difficult for care 
staff to support3,4,5. These behaviours are often 
linked to poor quality care6. Research shows that 
training staff in the principles of person-centred 
care provides them with the skills they need to 
prevent and support distressing behaviours7. 
However, without extra support for staff to build 
on their training, these benefits soon disappear7. 
Dementia Care Mapping8 is a tool that has been 
used to help staff to continue applying person-
centred care training in practice. However, there 
is limited robust research about how effective it 
is. It is also a relatively complex tool to master. 
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EPIC trial design 
Once residents, relatives and staff have consented 
to take part and provided baseline data, care homes 
are randomly allocated (3:2) to receive either Usual 
Care (UC) + Dementia Care Mapping (DCM) or UC 
alone. 
DCMTM involves observing the experience of care from 
the point of view of people with dementia and then 
feeding this back to staff, who use this information to 
look at ways to improve.  The below illustrates the DCM  
‘cycle’. 
 
 
 
 
 
 
 
 
The EPIC trial is looking at whether DCM is effective 
and good value for money when used for this purpose 
in care homes. 
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Dementia Care Mapping (DCMTM) 
1. Mapper credentials 
a) In consultation with the 
Care Home Manager (see 
figure 1), Researchers identify 
two members of staff at each 
home who meet the criteria to 
be a ‘mapper’. Mappers 
receive an information sheet, 
discuss the role and provide 
consent. 
b) Suitability, eligibility and 
consent data collected. 
2. Mapper training 
a) Standardised training is 
provided by DCM trainers from 
the University of Bradford – this 
is a 4 day course with 
assessment, feedback and 
criteria for passing the course. 
Re-sits are undertaken if any 
elements are failed. 
b) The DCM trainer provides 
data re: attendance and pass 
mark. 
3. Delivery with feedback 
a) The first ‘cycle’ of DCM is 
undertaken with DCM expert 
support. This allows for 
consolidation of skills in 
practice and inter-rater 
reliability assessment.  
b) Expert rating of 
performance provided. 
Mappers send raw mapping 
data to the research office for 
review. 
4. Maintenance 
a) Thereafter mappers are 
required to undertake cycles 
two and three on their own. 
They are provided with dates to 
do so at the outset. 
b) Mappers send raw mapping 
data to research office for 
review, alongside data regarding 
staff attendance at briefing and 
feedback sessions. 
 
DCM delivery     The intention in the EPIC Trial was to a) ensure intervention fidelity and b) monitor adherence via the following means: 
Problems encountered     During the pilot phase (first few homes) problems with implementation were identified: 
Mappers recruited with sub-
optimal skills. 
Some mappers dropped out 
prior to the training course, 
meaning more had to be 
recruited. 
Mappers unable to attend 
training at the last minute 
(commitments at the care 
home) 
Some mappers overwhelmed 
by the intensity of the course. 
Difficulty scheduling suitable 
dates for expert support .  
Last-minute cancellations. 
Delay in producing the DCM 
report due to time pressures 
and lack of confidence. 
From early experience, it was 
felt that some mappers may not 
remember, or be motivated, to 
continue with later cycles 
without support.  
 
Solutions  Problems were countered via the following means, with the Clinical Trials Research Unit (CTRU) as a central point of contact: 
• Provision of additional materials to support mapper selection 
(researcher guidance, information for mappers, option to speak to a 
DCM expert to discuss the role).  
• Early recruitment of mappers to allow staff rota scheduling to fit with 
training. 
• Researchers emphasise key importance of mapper role to the research, 
and discuss time commitments with manager & mappers. 
• Mappers asked to write a 500 word piece on what they understand by 
DCM and why they want to be a mapper. This is reviewed by the DCM 
expert and CI. Mappers contacted by CI / expert if any concerns. 
Problems fed back to the researchers. 
• DCM expert support dates 
scheduled early – at time of 
CH consent.  
• Researchers speak to CH 
manager and rota manager 
to ensure mappers will be 
given time to map within 
usual working hours. 
• CTRU chase mapping data 
via the DCM experts. 
 
• CTRU monitor dates each cycle 
is due and send reminder 
emails, text messages and 
newsletters to mappers, along 
with mapping materials ahead 
of each cycle.  
• Any issues flagged as a 
problem by the experts at cycle 
one are followed up, and DCM 
experts may provide further 
telephone support. 
• Missing mapping data chased 
via the DCM experts. 
Discussion 
Introducing methods to enhance delivery was seen as an appropriate and necessary 
approach when balanced against the alternative – i.e. the possibility of completing a 
definitive, pragmatic trial with potential for a negative result arising from sub-optimal 
implementation rather than actual intervention ineffectiveness. 
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Care home staff at the DCM homes receive standard 
training to become ‘mappers’. They then undertake 
3 cycles of DCM at around 3, 8 and 13 months post-
randomisation. Mappers are supported by DCM 
experts for their first cycle. 
Residents, relatives and staff provide trial 
outcome data at 6 and 16 months post 
randomisation in all participating homes. 
Staff and DCM experts provide data to evidence 
intervention delivery in the care homes. 
